✓
Open
21 Jan 2026
✓
Close
23 Jan 2026
3
Allotment
—
✓
Listing
Thu, Jan 29, 2026
Price Band
₹128 to ₹135
Issue Size
57,40,000 shares (agg. up to ₹77 Cr)
Lot Size
1,000 Shares
Listing Date
Thu, Jan 29, 2026
Latest GMP
₹22.5
Est. Gain
16.67%
✦ AI Insight
GMP Trend
29-01-2026₹22.5Est. ₹157.5+16.67%
28-01-2026₹22.5Est. ₹157.5+16.67%
27-01-2026₹20Est. ₹155+14.81%
Live Subscription
| Category | Subscription (times) |
|---|---|
| Total | 52.19x |
Restated Financials (₹ Cr.)
| Period Ended | 30 Sep 2025 | 31 Mar 2025 | 31 Mar 2024 | 31 Mar 2023 |
|---|---|---|---|---|
| Assets | 78.12 | 66.79 | 43.91 | 39.48 |
| Total Income | 48.65 | 76.95 | 67.57 | 89.38 |
| Profit After Tax | 8.14 | 12.10 | 3.41 | 7.60 |
| EBITDA | 12.83 | 19.11 | 7.34 | 11.03 |
| NET Worth | 36.13 | 23.88 | 11.78 | 8.37 |
| Reserves and Surplus | 20.61 | 23.73 | 11.63 | 8.22 |
| Total Borrowing | 25.07 | 31.20 | 23.18 | 19.87 |
| Amount in ₹ Crore |
Peer Comparison
| Company | Issue Type | Issue Size | Issue Price | PE Ratio | Listing Day Close | Listing Gain/Loss % | LTP |
|---|---|---|---|---|---|---|---|
| Curis Lifesciences Ltd. | SME | ₹27.52 Cr | ₹128 | 12.44 | ₹141.00 | +10.16% | ₹109.00 (+3.76%) |
| Aptus Pharma Ltd. | SME | ₹13.02 Cr | ₹70 | 11.29 | ₹84.84 | +21.20% | ₹240.60 (-3.51%) |
| Asston Pharmaceuticals Ltd. | SME | ₹27.56 Cr | ₹123 | 17.83 | ₹124.95 | +1.59% | ₹67.20 (-8.57%) |
| Influx Healthtech Ltd. | SME | ₹58.57 Cr | ₹96 | 13.04 | ₹126.20 | +31.46% | ₹282.15 (-2.71%) |
| Astonea Labs Ltd. | SME | ₹37.67 Cr | ₹135 | 27.36 | ₹135.65 | +0.48% | ₹278.00 (-1.77%) |
| Accretion Pharmaceuticals Ltd. | SME | ₹29.75 Cr | ₹101 | 21.29 | ₹82.95 | -17.87% | ₹165.65 (-0.21%) |
| Amwill Health Care Ltd. | SME | ₹59.98 Cr | ₹111 | 13.81 | ₹93.25 | -15.99% | ₹43.39 (+3.04%) |
| Corona Remedies Ltd. | Mainboard | ₹655.37 Cr | ₹1062 | 43.47 | ₹1,438.40 | +35.44% | ₹2,062.20 (+0.04%) |
| Rubicon Research Ltd. | Mainboard | ₹1,377.50 Cr | ₹485 | 55.75 | ₹628.20 | +29.53% | ₹1,439.60 (+2.37%) |
| Amanta Healthcare Ltd. | Mainboard | ₹126.00 Cr | ₹126 | 34.59 | ₹141.75 | +12.50% | ₹168.00 (+1.44%) |
| Anlon Healthcare Ltd. | Mainboard | ₹121.03 Cr | ₹91 | 17.67 | ₹91.73 | +0.80% | ₹14.73 (-3.22%) |
Objects of the Issue
| # | Issue Objects | Est Amt (₹ Cr.) |
|---|---|---|
| 1 | Capital Expenditure for Construction and Development of Telemedicine Operational Facilities | 13.67 |
| 2 | Purchase of CRM Software and Hardware Infrastructure | 1.42 |
| 3 | Human Resources | 5.44 |
| 4 | Repayment/Prepayment of loan | 12.50 |
| 5 | Working Capital Requirement | 22.90 |
| 6 | General Corporate Purposes | 10.00 |
| 7 | Issue Expenses | 11.57 |
| Total | 77.49 |
About KRM Ayurveda IPO
Incorporated on 3 September 2019, KRM Ayurveda Ltd. is operating a network of hospitals and clinics across multiple cities in India as well as marked its presence in abroad through telemedicines consulting and sales. They manufacture Ayurvedic products, herbal and botanical remedies, medicines, supplements and possibly skin care / wellness related items. Presently, the company runs 6 (Six) Hospitals and 5 (Five) Clinics at different locations in the country. Hospitals and Clinics are equipped with the following infrastructure & facilities: Beds, including general wards and premium rooms. Panchakarma treatment units. Herbal pharmacy and medicine preparation unit. Ayurvedic diet kitchen Consultation chambers for Vaidyas (Ayurvedic physicians). In-house yoga and meditation hall. Services: In-Patient & Out-Patient Care: Treatment for chronic diseases, lifestyle disorders, and post-operative rehabilitation. Panchakarma Therapies: Detoxification and rejuvenation programs. Specialized Clinics: Orthopedic care, skin and hair care, women’s wellness, geriatric care. Wellness Packages: Stress management, weight management, preventive health plans. Medicinal Sales: Dispensary of in-house and c
Contact Details
KRM Ayurveda Ltd. AddressA-16, G T Karnal RoadIndustrial AreaDelhi, New Delhi, 110033+91- 9289101700compliance@krmayurveda.comVisit Website